Vicryl Suture | Materials, Types, Uses, Effectiveness

Vicryl (polyglactin 910) is a synthetic, absorbable suture that is often braided and is produced by Ethicon Inc., a Johnson & Johnson subsidiary. Additionally, a monofilament variant is produced for use in ophthalmology. It is suggested for ligation and approximation of soft tissue. In tissue, the suture retains its tensile strength for around two to three weeks before being totally dissolved by acid hydrolysis 56 to 70 days later. Triclosan (“Vicryl Plus Antibacterial”) to give antibacterial protection of the suture line. Vicryl and other polyglycolic-acid sutures may also be treated for more rapid breakdown (“Vicryl Rapide”) in rapidly healing tissues such as mucous membranes.

Vicryl’s usage is not advised in the closure of any cutaneous wound exposed to the air due to its poor absorption and frequent braiding, as this causes moisture to be drawn from the healing tissue to the skin and allows bacteria and irritants to enter the wound. High reactivity to the pollutants, inadequate wound healing, and ultimately infection may result from this.

Although Ethicon owns the trademark “Vicryl,” the phrase has come to apply to any synthetic absorbable suture predominantly comprised of polyglycolic acid. PolySyn, Surgicryl, Polysorb, and Dexon are further brands of polyglycolic acid sutures that are produced by various businesses. the suture is a copolymer comprising glycolide and lactide, which is a cyclic diester of lactic acid (a cyclic diester of glycolic acid). This suture is typically braided, coloured, or undyed and decays at a rate of 75% after two weeks, 50% after three weeks, and 25% after four weeks (i.e., the sutures retain that proportion of tensile strength at those dates)